Apple continues to expand its wearable product line. In line with this, the company recently introduced the iPhone 15 series and the Apple Watch Series 9 models alon with Apple Watch Ultra 2 at an event. The US tech giant is already winning over users with its wearable technologies and the health tracking features they bring. For this reason, the Watch Series 9 is also expected to achieve strong sales. However, the company is not satisfied with this. Here are the details…

Apple Taps Veteran Chip Executive to Lead Glucose Tracker Project

Apple is one of the world’s largest companies, with tens of thousands of employees. This allows the company to bring together the world’s most talented teams to create technological marvels. Now, with an important appointment, work is beginning on a feature that could revolutionize health technologies. According to a recent announcement, Apple has appointed Tim Millet, its vice president of platform architecture, as the new leader of its team developing a noninvasive blood sugar monitor.

Millet takes over the project after it was left without a dedicated head for several months following the death of scientist Bill Athas at the end of last year. Millet is a veteran of Apple, having worked at the company for about 19 years. He has held a variety of engineering and management positions, including leading the development of the A-series chips for the iPhone and iPad.

He is also a member of the Apple Health team, which is responsible for developing the company’s health-related products and services. Apple has been working on the glucose tracker project for several years, but it has faced challenges in developing a device that is both accurate and affordable. The company has also had to navigate regulatory hurdles, from various authorities.

It is unclear when Apple plans to release a glucose tracker. However, the company’s decision to appoint Millet as the project leader suggests that it is making progress and is committed to bringing the device to market.

RELATED:

(via)